世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033320

CRISPRおよびCas遺伝子市場規模、シェア、動向分析レポート、予測2022-2030

Grand View Research Inc.

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2022 - 2030

発刊日 2022/10

言語英語

体裁PDF/170ページ

ライセンス/価格170ページ

0000033320

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

CRISPRおよびCas遺伝子の市場規模、シェア、動向分析レポートは、最終ユーザー別(CRO、バイオテクノロジーおよび製薬企業)、用途別(生物医学、農業)、製品&サービス別、地域別、およびセグメント予測、2022〜2030

レポートの概要
世界の CRISPR および Cas 遺伝子の市場規模は、2021 年に 20 億 5000 万ドルと評価され、2022 年から 2030 年までに17.9% のCAGRで拡大が見込まれます。バイオテクノロジー研究における最近の進歩によって、CRISPR および Cas 遺伝子システムは、直接または間接的に人間の健康に役立つ広範な応用領域を見つけることが可能になりました。たとえば、個人の DNA を操作する体細胞遺伝子編集は、HIV、鎌状赤血球症、トランスサイレチン アミロイドーシスなどの疾患の治療に使用されています。この技術は、さまざまな種類のがんに対する新しい治療オプションの一つとして期待されています。CRISPR および Cas 遺伝子システムの技術的進歩は、癌の研究と治療の分野に革命をもたらしました。

レポート詳細

目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 Market Share Calculations
1.9 List Of Secondary Sources
1.10 List Of Abbreviations
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.11.3 Objective 3
1.11.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Crispr & Cas Genes Market Variables, Trends And Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Growing Need For Novel Therapeutics
3.2.2 Rising Demand For Gene Editing
3.3.3 Rising Incidence Of Cancer
3.3 Market Restraint Analysis
3.3.1 Off-Target Effects Of Crispr Technology
3.3.2 High-Cost Factor, Intellectual Property Disputes & Ethical Dilemma
3.4 Crispr & Cas Genes Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s

Chapter 4 Product & Service Business Analysis
4.1 Crispr And Cas Genes Market: Product & Service Movement Analysis
4.1.1 By Product
4.1.1.1 Global Crispr And Cas Genes Products Market, 2018 - 2030 (USD Million)
4.1.1.2 Kits & Enzymes
4.1.1.2.1 Global Crispr And Cas Genes Kits And Enzymes Market, 2018 - 2030 (USD Million)
4.1.1.2.2 Vector-Based Cas9
4.1.1.2.2.1 Global Vector-Based Crispr And Cas Genes Market, 2018 - 2030 (USD Million)
4.1.1.2.3 Dna-Free Cas9
4.1.1.2.3.1 Global Dna-Free Crispr And Cas Genes Market, 2018 - 2030 (USD Million)
4.1.1.3 Libraries
4.1.1.3.1 Global Crispr And Cas Genes Libraries Market, 2018 - 2030 (USD Million)
4.1.1.4 Design Tools
4.1.1.4.1 Global Crispr And Cas Genes Design Tool Market, 2018 - 2030 (USD Million)
4.1.1.5 Antibodies
4.1.1.5.1 Global Crispr And Cas Genes Antibodies Market, 2018 - 2030 (USD Million)
4.1.1.6 Others
4.1.1.6.1 Global Crispr And Cas Genes Market For Others, 2018 - 2030 (USD Million)
4.1.2 By Service
4.1.2.1 Global Crispr And Cas Genes Service Market, 2018 - 2030 (USD Million)
4.1.2.2 Cell Line Engineering
4.1.2.2.1 Global Cell Engineering Services Market, 2018 - 2030 (USD Million)
4.1.2.3 gRNA Design
4.1.2.3.1 Global gRNA Design Market, 2018 - 2030 (USD Million)
4.1.2.4 Microbial Gene Editing
4.1.2.4.1 Global Microbial Gene Editing Market, 2018 - 2030 (USD Million)
4.1.2.5 Dna Synthesis
4.1.2.5.1 Global Dna Synthesis Market, 2018 - 2030 (USD Million)

Chapter 5 Application Business Analysis
5.1 Crispr And Cas Genes Market: Application Movement Analysis
5.1.1 Biomedical
5.1.1.1 Global Crispr And Cas Genes Market For Biomedical, 2018 - 2030 (USD Million)
5.1.1.2 Genome Engineering
5.1.1.2.1 Global Crispr And Cas Genes Market For Genome Engineering, 2018 - 2030 (USD Million)
5.1.1.3 Disease Model Studies
5.1.1.3.1 Global Crispr And Cas Genes Market For Disease Model Studies, 2018 - 2030 (USD Million)
5.1.1.4 Functional Genomics
5.1.1.4.1 Global Crispr And Cas Genes Market For Functional Genomics, 2018 - 2030 (USD Million)
5.1.1.5 Epigenetics
5.1.1.5.1 Global Crispr And Cas Genes Market For Epigenetics, 2018 - 2030 (USD Million)
5.1.1.6 Others
5.1.1.6.1 Global Crispr And Cas Genes Market For Others, 2018 - 2030 (USD Million)
5.1.2 Agriculture
5.1.2.1 Global Crispr And Cas Genes Market For Agriculture, 2018 - 2030 (USD Million)

Chapter 6 End-Use Business Analysis
6.1 Crispr And Cas Genes Market: End-Use Movement Analysis
6.1.1 Biotechnology & Pharmaceutical Companies
6.1.1.1 Global Crispr And Cas Genes Market For Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
6.1.2 Academics & Government Research Institutes
6.1.2.1 Global Crispr And Cas Genes Market For Academics & Government Research Institutes, 2018 - 2030 (USD Million)
6.1.3 Contract Research Organizations (Cros)
6.1.3.1 Global Crispr And Cas Genes Market For Contract Research Organizations (Cros), 2018 - 2030 (USD Million)

Chapter 7 Market Categorization: Regional Estimates & Trend Analysis by Product, Application & End-use
7.1 Regional Market Snapshot
7.2 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East And Africa
7.3 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
7.4 North America
7.4.1 North America CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
7.4.2 U.S.
7.4.2.1 U.S. CRISPR & Cas Gene Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.4.3 Canada
7.4.3.1 Canada CRISPR & Cas Genes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.5 Europe
7.5.1 Europe CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
7.5.2 Germany
7.5.2.1 Germany CRISPR & Cas Gene Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.5.3 U.K.
7.5.3.1 U.K. CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.4 France
7.5.4.1 France CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.5 Italy
7.5.5.1 Italy CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.6 Spain
7.5.6.1 Spain CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Asia Pacific
7.6.1 Asia Pacific CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
7.6.2 Japan
7.6.2.1 Japan CRISPR & Cas Genes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.6.3 China
7.6.3.1 China CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.4 South Korea
7.6.4.1 South Korea CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.5 India
7.6.5.1 India CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Latin America
7.7.1 Latin America CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7.2 Brazil
7.7.2.1 Brazil CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7.3 Mexico
7.7.3.1 Mexico CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Middle East & Africa (Mea)
7.8.1 MEA CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8.2 South Africa
7.8.2.1 South Africa CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8.3 Saudi Arabia
7.8.3.1 Saudi Arabia CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape
8.1 Top CRISPR Innovators and Their Research Focus
8.2 Strategy Framework
8.3 Market Participant Categorization
8.4 Company Profiles
8.4.1 CARIBOU BIOSCIENCES
8.4.1.1 Company Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 ASTRAZENECA
8.4.2.1 Company Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 INTELLIA THERAPEUTICS, INC.
8.4.3.1 Company Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 ADDGENE
8.4.4.1 Company Overview
8.4.4.2 Financial Performance
8.4.4.3 Product Benchmarking
8.4.5 CRISPR THERAPEUTICS
8.4.5.1 Company Overview
8.4.5.2 Financial Performance
8.4.5.3 Product Benchmarking
8.4.5.4 Strategic Initiatives
8.4.6 NEW ENGLAND BIOLABS
8.4.6.1 Company Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 THERMO FISHER SCIENTIFIC, INC.
8.4.7.1 Company Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 SYNTHEGO
8.4.8.1 Company Overview
8.4.8.2 Financial Performance
8.4.8.3 Product Benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 MAMMOTH BIOSCIENCES
8.4.9.1 Company Overview
8.4.9.2 Financial Performance
8.4.9.3 Product Benchmarking
8.4.9.4 Strategic Initiatives
8.4.10 INSCRIPTA, INC.
8.4.10.1 Company Overview
8.4.10.2 Financial Performance
8.4.10.3 Product Benchmarking
8.4.10.4 Strategic Initiatives
8.4.11 CIBUS
8.4.11.1 Company Overview
8.4.11.2 Financial Performance
8.4.11.3 Product Benchmarking
8.4.11.4 Strategic Initiatives
8.4.12 BEAM THERAPEUTICS
8.4.12.1 Company Overview
8.4.12.2 Financial Performance
8.4.12.3 Product Benchmarking
8.4.12.4 Strategic Initiatives
8.4.13 PLANTEDIT
8.4.13.1 Company Overview
8.4.13.2 Product Benchmarking
8.4.14 VERTEX PHARMACEUTICALS INCORPORATED
8.4.14.1 Company Overview
8.4.14.2 Financial Performance
8.4.14.3 Product Benchmarking
8.4.14.4 Strategic Initiatives
8.4.15 GENSCRIPT
8.4.15.1 Company Overview
8.4.15.2 Financial Performance
8.4.15.3 Product Benchmarking
8.4.15.4 Strategic Initiatives
8.4.16 INTEGRATED DNA TECHNOLOGIES
8.4.16.1 Company Overview
8.4.16.2 Financial Performance
8.4.16.3 Product Benchmarking
8.4.16.4 Strategic Initiatives
8.4.17 LONZA
8.4.17.1 Company Overview
8.4.17.2 Financial Performance
8.4.17.3 Product Benchmarking
8.4.17.4 Strategic Initiatives
8.4.18 MERCK
8.4.18.1 Company Overview
8.4.18.2 Financial Performance
8.4.18.3 Product Benchmarking
8.4.18.4 Strategic Initiatives
8.4.19 HERA BIOLABS
8.4.19.1 Company Overview
8.4.19.2 Product Benchmarking
8.4.19.3 Strategic Initiatives
8.4.20 ORIGENE TECHNOLOGIES, INC.
8.4.20.1 Company Overview
8.4.20.2 Financial Performance
8.4.20.3 Product Benchmarking
8.4.21 RECOMBINETICS, INC.
8.4.21.1 Company Overview
8.4.21.2 Financial Performance
8.4.21.3 Product Benchmarking
8.4.21.4 Strategic Initiative

List of Tables
Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 5 Global CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 6 Global CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 7 Global CRISPR and Cas Genes Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 10 North America CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 11 North America CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 12 U.S. CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 13 U.S. CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 14 U.S. CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 15 Canada CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 16 Canada CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 17 Canada CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 18 Europe CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
Table 19 Europe CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 20 Europe CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 21 Europe CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 22 Germany CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 23 Germany CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 24 Germany CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 25 U.K. CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 26 U.K. CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 27 U.K. CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 28 France CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 29 France CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 30 France CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 31 Italy CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 32 Italy CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 33 Italy CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 34 Spain CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 35 Spain CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 36 Spain CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 37 Asia Pacific CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
Table 38 Asia Pacific CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 39 Asia Pacific CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 40 Asia Pacific CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 41 China CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 42 China CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 43 China CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 44 Japan CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 45 Japan CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 46 Japan CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 47 India CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 48 India CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 49 India CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 50 South Korea CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 51 South Korea CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 52 South Korea CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 53 Latin America CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
Table 54 Latin America CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 55 Latin America CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 56 Latin America CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 57 Brazil CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 58 Brazil CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 59 Brazil CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 60 Mexico CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 61 Mexico CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 62 Mexico CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 63 Argentina CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 64 Argentina CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 65 Argentina CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 66 Middle East and Africa CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
Table 67 Middle East and Africa CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 68 Middle East and Africa CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 69 Middle East and Africa CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 70 South Africa CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 71 South Africa CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 72 South Africa CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 CRISPR and Cas genes, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 Global CRISPR and Cas genes Market, for Product, 2018 - 2030 (USD Million)
Fig. 16 Global CRISPR and Cas genes Market, for Kits & Enzymes, 2018 - 2030 (USD Million)
Fig. 17 Global CRISPR and Cas genes Market, for Vector-based Cas9 2018 - 2030 (USD Million)
Fig. 18 Global CRISPR and Cas genes Market, for DNA-free Cas9 2018 - 2030 (USD Million)
Fig. 19 Global CRISPR and Cas genes Market, for Libraries, 2018 - 2030 (USD Million)
Fig. 20 Global CRISPR and Cas genes Market, for Design Tool, 2018 - 2030 (USD Million)
Fig. 21 Global CRISPR and Cas genes Market, for Antibodies , 2018 - 2030 (USD Million)
Fig. 22 Global CRISPR and Cas genes Market, for Others , 2018 - 2030 (USD Million)
Fig. 23 Global CRISPR and Cas genes Market, for Service, 2018 - 2030 (USD Million)
Fig. 24 Global CRISPR and Cas genes Market, for Cell Line Engineering , 2018 - 2030 (USD Million)
Fig. 25 Global CRISPR and Cas genes Market, for gRNA Design , 2018 - 2030 (USD Million)
Fig. 26 Global CRISPR and Cas genes Market, for Microbial Gene Editing , 2018 - 2030 (USD Million)
Fig. 27 Global CRISPR and Cas genes Market, for DNA synthesis , 2018 - 2030 (USD Million)
Fig. 28 Global CRISPR and Cas genes Market, for Biomedical , 2018 - 2030 (USD Million)
Fig. 29 Global CRISPR and Cas genes Market, for Genome Engineering, 2018 - 2030 (USD Million)
Fig. 30 Global CRISPR and Cas genes Market, for Disease Model Studies, 2018 - 2030 (USD Million)
Fig. 31 Global CRISPR and Cas genes Market, for Functional Genomics , 2018 - 2030 (USD Million)
Fig. 32 Global CRISPR and Cas genes Market, for Epigenetics, 2018 - 2030 (USD Million)
Fig. 33 Global CRISPR and Cas genes Market, for Others , 2018 - 2030 (USD Million)
Fig. 34 Global CRISPR and Cas genes Market, for Agricultural , 2018 - 2030 (USD Million)
Fig. 35 Global CRISPR and Cas genes Market, for Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 36 Global CRISPR and Cas genes Market, for Academics & Government Research Institutes, 2018 - 2030 (USD Million)
Fig. 37 Global CRISPR and Cas genes Market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)
Fig. 38 Regional Outlook, 2021 & 2030
Fig. 39 North America CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 40 U.S. CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 41 Canada CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 42 Europe CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 43 Germany CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 44 U.K. CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 45 France CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 46 Italy CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 47 Spain CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 49 Japan CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 50 China CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 51 India CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 52 Latin America CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 53 Brazil CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 54 Mexico CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 55 Middle East and Africa CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 56 South Africa CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia CRISPR and Cas genes Market, 2018 - 2030 (USD Million)

この商品のレポートナンバー

0000033320

TOP